Evidence map›Paper›PMID 42368595›Full record

ArticleEULAR rheumatology open2025

Altered somatosensory profiles in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and systemic sclerosis.

Simon M Petzinna, Claus-Juergen Bauer, Ruth S Schrapper, Martin Mücke, Charlotte Behning, Tim T A Bender, Pantelis Karakostas, Valentin S Schäfer

Abstract read
In one paragraph

Article in EULAR rheumatology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Simon M PetzinnaMedical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
Claus-Juergen BauerMedical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
Ruth S SchrapperMedical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
Martin MückeInstitute for Digitalization and General Medicine, University Hospital of Aachen, Aachen, Germany.
Charlotte BehningDepartment of Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany.
Tim T A BenderCenter for Rare Diseases Bonn, University Hospital Bonn, Bonn, Germany.
Pantelis KarakostasMedical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.
Valentin S SchäferMedical Clinic III for Oncology, Hematology, Immune-Oncology and Rheumatology, University Hospital Bonn, Bonn, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This exploratory study aimed to examine the somatosensory profiles of patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), axial spondyloarthritis (axSpA), and systemic sclerosis (SSc) using quantitative sensory testing (QST). We sought to identify distinct patterns of sensory alterations to enhance the understanding of pain mechanisms in these conditions and to generate hypotheses for future mechanistic research and therapy approaches. Methods: Patients with RA, PsA, axSpA, and SSc underwent QST on both hands to evaluate all somatosensory submodalities. Standardised assessment, following the German Research Network on Neuropathic Pain protocol, included mechanical detection threshold (MDT) and vibration detection threshold (VDT) as well as thermal detection and pain thresholds. Results: We enrolled 80 patients (20 with RA, PsA, axSpA, SSc) and 20 controls. Significant differences in MDT (RA: Conclusions: Patients with RA, PsA, axSpA, and SSc demonstrate significant alterations in somatosensory processing, including abnormal MDT and VDT, and pathological allodynia that appear independent of inflamed areas. These sensory changes do not correlate with disease activity, duration, inflammatory markers, or therapeutic approach, indicating that they may result from mechanisms distinct from inflammation.

Identifiers

PMID42368595
PMCPMC13292141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.